Hydroxyurea use in young infants with sickle cell disease.

Schuchard, Sarah B; Lissick, Jennifer R; Nickel, Amanda; Watson, David; Moquist, Kristin L; Blaylark, Rae M; Nelson, Stephen C

Schuchard, Sarah B; Lissick, Jennifer R; Nickel, Amanda; Watson, David; Moquist, Kristin L; Blaylark, Rae M; Nelson, Stephen C.

Afiliação

Schuchard SB; SSM Health Cardinal Glennon Children's Hospital, St. Louis, Missouri.
Lissick JR; Children's Hospital and Clinics of Minnesota, Minneapolis, Minnesota.
Nickel A; Children's Hospital and Clinics of Minnesota, Minneapolis, Minnesota.
Watson D; Children's Hospital and Clinics of Minnesota, Minneapolis, Minnesota.
Moquist KL; Children's Hospital and Clinics of Minnesota, Minneapolis, Minnesota.
Blaylark RM; Children's Hospital and Clinics of Minnesota, Minneapolis, Minnesota.
Nelson SC; Children's Hospital and Clinics of Minnesota, Minneapolis, Minnesota.

Pediatr Blood Cancer ; 66(7): e27650, 2019 07.

Article em En | MEDLINE | ID: mdl-30729675

Assuntos

Anemia Falciforme/tratamento farmacológico; Hidroxiureia/administração & dosagem; Adolescente; Adulto; Anemia Falciforme/sangue; Anemia Falciforme/patologia; Criança; Feminino; Seguimentos; Humanos; Hidroxiureia/efeitos adversos; Lactente; Masculino; Estudos Retrospectivos

Palavras-chave

hydroxyurea; infants; sickle cell disease

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hidroxiureia / Anemia Falciforme Tipo de estudo: Observational_studies / Prognostic_studies Limite: Adolescent / Adult / Child / Female / Humans / Infant / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google